QUINN WILLIAM P. (Chief Financial Officer) purchased 5.7% of their position (125.00 shares) of BOLT BIOTHERAPEUTICS, INC. on the open market
Open‑market purchase worth $575.88 — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/4/2026ACC: 0001193125-26-037697
Officer· Chief Financial Officer
Since Feb 2021
+20.13K
Net shares
Net buyer
$575.88
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
20.13K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+125.00
Price / share
$4.61
Trade value
$575.88
% of position
5.7%
12/5/2025
2.19K→2.31K
Total
Net shares
+125.00
Net value
$575.88
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/5/2025 | P · Purchase | +125.00 | $4.61 | $575.88 | 5.7% | 2.19K | 2.31K |
| Total | +125.00 | $575.88 | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
20K shares
Shares
+20K
Strike price
6.7100
Held after
20K
Exercisable
—
1/28/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock20K shares | 1/28/2026 | A · Award | +20K | 6.7100 | — | 20K |